| Financial Year |
March 31 2023 |
| Monetary Funds |
685,346,592.85 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,948,260.96 |
| Accounts Receivable |
1,552,585,582.56 |
| Advances to Suppliers |
340,921,770.70 |
| Other Receivables |
377,908,712.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
28,835,721.52 |
| Dividend Receivable |
-- |
| Inventories |
1,253,170,938.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
155,645,519.25 |
| Total Current Assets |
4,835,843,342.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
95,775,806.32 |
| Long-term Equity Investment |
281,513,928.62 |
| Investment Properties |
618,496,710.99 |
| Fixed Assetes |
1,050,694,371.85 |
| Under-construction Projects |
8,602,584.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
486,285,641.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
98,399,166.00 |
| Deferred Income Tax Assets |
129,665,272.29 |
| Other Non-Current Assets |
7,890,237.70 |
| Sub-Total of Non-Current Assets |
2,793,560,792.99 |
| Total Assets |
7,629,404,135.54 |
| Short-Term Loans |
339,740,616.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,080,883,062.61 |
| Accounts Payable |
1,592,579,814.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,979,725.64 |
| Taxes Payable |
116,530,937.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
387,289,219.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,383,090.83 |
| Other Current Liabilities |
22,138,577.05 |
| Sub-Total of Current Liabilities |
3,926,241,716.92 |
| Long-term Loans |
872,517,582.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,523,745.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
954,689,904.69 |
| Total Liabilities |
4,880,931,621.61 |
| Paid-In Capital(Or Share Stock) |
798,014,769.00 |
| Capital Surplus |
1,177,553,852.76 |
| Surplus Reserve |
128,484,416.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
414,982,574.42 |
| Minority Stockholder's Interest |
229,258,433.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,519,214,080.87 |
| Owner's Equity（Stockholder's Equity） |
2,748,472,513.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,629,404,135.54 |
